1. Home
  2. CLIR vs RNAZ Comparison

CLIR vs RNAZ Comparison

Compare CLIR & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ClearSign Technologies Corporation (DE)

CLIR

ClearSign Technologies Corporation (DE)

HOLD

Current Price

$1.54

Market Cap

23.9M

Sector

Industrials

ML Signal

HOLD

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

HOLD

Current Price

$1.04

Market Cap

27.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLIR
RNAZ
Founded
2008
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.9M
27.9M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
CLIR
RNAZ
Price
$1.54
$1.04
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
18.4K
★ 19.2K
Earning Date
11-16-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $530,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$280.19
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.39
$1.28
52 Week High
$16.40
$12.60

Technical Indicators

Market Signals
Indicator
CLIR
RNAZ
Relative Strength Index (RSI) 25.88 25.80
Support Level $0.39 N/A
Resistance Level $2.82 $1.93
Average True Range (ATR) 0.26 0.16
MACD -0.03 -0.02
Stochastic Oscillator 8.42 6.42

Price Performance

Historical Comparison
CLIR
RNAZ

About CLIR ClearSign Technologies Corporation (DE)

ClearSign Technologies Corp is engaged in designing and develop technologies for the purpose of decarbonization and improving key performance characteristics of industrial and commercial combustion systems, including emission and operational performance, energy efficiency and overall cost-effectiveness. Its ClearSign Core technology has been proved to be in full scale industrial test furnaces and boilers and first customer installations are currently operating in normal commercial applications The company offers products that include process burners, boiler burners, flares, and ClearSign Eye. The company operates in one segment: Combustion segment. The products of the company include: Process Burners, Midstream and Power, Flares, Boiler Burners, and Sensing Technology.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Share on Social Networks: